Annual CFO:
-$142.11M+$18.85M(+11.71%)Summary
- As of today, CNTA annual cash from operations is -$142.11 million, with the most recent change of +$18.85 million (+11.71%) on December 31, 2024.
- During the last 3 years, CNTA annual cash from operations has fallen by -$5.97 million (-4.39%).
Performance
CNTA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$22.92M+$34.55M(+60.12%)Summary
- As of today, CNTA quarterly cash from operations is -$22.92 million, with the most recent change of +$34.55 million (+60.12%) on June 1, 2025.
- Over the past year, CNTA quarterly cash from operations has increased by +$17.71 million (+43.59%).
- CNTA quarterly cash from operations is now -80.94% below its all-time high of -$12.67 million, reached on March 31, 2021.
Performance
CNTA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$144.61M+$17.71M(+10.91%)Summary
- As of today, CNTA TTM cash from operations is -$144.61 million, with the most recent change of +$17.71 million (+10.91%) on June 1, 2025.
- Over the past year, CNTA TTM cash from operations has increased by +$1.76 million (+1.21%).
- CNTA TTM cash from operations is now -1041.72% below its all-time high of -$12.67 million, reached on March 31, 2021.
Performance
CNTA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CNTA Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +11.7% | +43.6% | +1.2% |
3Y3 Years | -4.4% | +61.5% | +27.4% |
5Y5 Years | -2339.7% | - | - |
CNTA Cash From Operations Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -4.4% | +29.1% | -5.1% | +60.1% | -10.6% | +29.1% |
5Y | 5-Year | >-9999.0% | +29.1% | -80.9% | +61.5% | -1041.7% | +29.1% |
All-Time | All-Time | >-9999.0% | +29.1% | -80.9% | +61.5% | -1041.7% | +29.1% |
CNTA Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$22.92M(+60.1%) | -$144.61M(+10.9%) |
Mar 2025 | - | -$57.47M(-35.5%) | -$162.32M(-14.2%) |
Dec 2024 | -$142.11M(+11.7%) | -$42.41M(-94.5%) | -$142.11M(-8.6%) |
Sep 2024 | - | -$21.81M(+46.3%) | -$130.80M(+10.6%) |
Jun 2024 | - | -$40.63M(-9.0%) | -$146.37M(+2.4%) |
Mar 2024 | - | -$37.26M(-19.8%) | -$149.96M(+6.8%) |
Dec 2023 | -$160.96M(+19.7%) | -$31.10M(+16.8%) | -$160.96M(+11.8%) |
Sep 2023 | - | -$37.38M(+15.4%) | -$182.58M(+0.5%) |
Jun 2023 | - | -$44.21M(+8.4%) | -$183.42M(+7.7%) |
Mar 2023 | - | -$48.27M(+8.4%) | -$198.70M(+0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$200.42M(-47.2%) | -$52.71M(-37.9%) | -$200.42M(+1.8%) |
Sep 2022 | - | -$38.22M(+35.8%) | -$204.00M(-2.5%) |
Jun 2022 | - | -$59.50M(-19.0%) | -$199.10M(-14.8%) |
Mar 2022 | - | -$49.99M(+11.2%) | -$173.47M(-27.4%) |
Dec 2021 | -$136.14M(>-9900.0%) | -$56.29M(-68.9%) | -$136.14M(-70.5%) |
Sep 2021 | - | -$33.32M(+1.6%) | -$79.85M(-71.6%) |
Jun 2021 | - | -$33.87M(-167.4%) | -$46.53M(-267.4%) |
Mar 2021 | - | -$12.67M | -$12.67M |
Dec 2020 | $0.00(+100.0%) | - | - |
Dec 2019 | -$5.83M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual cash from operations?
- What is the all-time high annual cash from operations for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual cash from operations year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly cash from operations year-on-year change?
- What is Centessa Pharmaceuticals plc TTM cash from operations?
- What is the all-time high TTM cash from operations for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM cash from operations year-on-year change?
What is Centessa Pharmaceuticals plc annual cash from operations?
The current annual cash from operations of CNTA is -$142.11M
What is the all-time high annual cash from operations for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual cash from operations is $0.00
What is Centessa Pharmaceuticals plc annual cash from operations year-on-year change?
Over the past year, CNTA annual cash from operations has changed by +$18.85M (+11.71%)
What is Centessa Pharmaceuticals plc quarterly cash from operations?
The current quarterly cash from operations of CNTA is -$22.92M
What is the all-time high quarterly cash from operations for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly cash from operations is -$12.67M
What is Centessa Pharmaceuticals plc quarterly cash from operations year-on-year change?
Over the past year, CNTA quarterly cash from operations has changed by +$17.71M (+43.59%)
What is Centessa Pharmaceuticals plc TTM cash from operations?
The current TTM cash from operations of CNTA is -$144.61M
What is the all-time high TTM cash from operations for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM cash from operations is -$12.67M
What is Centessa Pharmaceuticals plc TTM cash from operations year-on-year change?
Over the past year, CNTA TTM cash from operations has changed by +$1.76M (+1.21%)